Environmental Pollutants and the Risk of Soft Tissue Sarcoma: A Pilot Study
NCT00611078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2011-01-20
Summary
The purpose of this study is to assess the feasibility of conducting a large hospital based case control study of the role of dioxins and dioxinlike polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs).
Conditions
- Soft Tissue Sarcoma
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Lawrence Engel, Ph.D. · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
Countries
- United States
Study Locations
More Related Trials
-
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
NCT00101127 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
NCT00058006 ·Status: COMPLETED ·Phase: PHASE2
-
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
NCT02201355 ·Status: TERMINATED ·Phase: PHASE1
-
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
NCT02492503 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
NCT00003065 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
NCT02075112 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma
NCT00189137 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00030472 ·Status: TERMINATED ·Phase: PHASE2
-
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
NCT02128906 ·Status: RECRUITING ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002922 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
NCT00002562 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Survivorship Care Plans in Head and Neck Cancer
NCT03106090 ·Status: TERMINATED ·Phase: NA
-
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
NCT02501278 ·Status: WITHDRAWN ·Phase: PHASE2
-
Docetaxel in Head and Neck Cancer
NCT00261703 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC
NCT02639858 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
NCT07062354 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
NCT02360501 ·Status: COMPLETED ·Phase: PHASE2
-
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
NCT00053794 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer
NCT01587820 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Phase II Study of TAS-106 to Treat Head and Neck Cancer
NCT00737360 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
NCT01847326 ·Status: COMPLETED ·Phase: PHASE1
-
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
NCT00072540 ·Status: WITHDRAWN ·Phase: PHASE2